Literature DB >> 10096772

Kupffer cell-mediated differential down-regulation of cytochrome P450 metabolism in rat hepatocytes.

N Milosevic1, H Schawalder, P Maier.   

Abstract

Nonparenchymal cells, particularly Kupffer cells, might play an important role in the modulation of xenobiotic metabolism in liver and its pharmacological and toxicological consequences. This intercellular communication via the exchange of soluble factors was investigated in primary rat Kupffer cells and hepatocytes. Freshly isolated rat Kupffer cells were seeded onto cell culture inserts and cocultured with 5 day old serum-free rat hepatocyte monolayer cultures at a ratio of 1:1 for 2 days. Hepatocyte cultures, Kupffer cell cultures or cocultures were treated with 0.1 ng/ml-10 microg/ml lipopolysaccharide (LPS). Within this concentration range, no significant toxicity was observed in either cell type. In LPS-exposed cocultures, tumor necrosis factor alpha (TNFalpha) levels rose up to 5 ng/ml within 5 h; nitric oxide (NO) levels increased up to 70 microM within 48 h of treatment, both in a dose-dependent fashion. The release of negative (albumin) and positive (alpha1-acid-glycoprotein) acute phase proteins from the hepatocytes was strongly down- and up-regulated, respectively. The simultaneous treatment of the cocultures with phenobarbital and LPS (10 ng/ml) or 3-methylcholanthrene and LPS (10 ng/ml) resulted in a strong down-regulation (85%) of the phenobarbital-induced cytochrome P450 (CYP) isoform CYP2B1 in the hepatocytes whereas the 3-methylcholanthrene-induced isoform CYP1A1 was only weakly affected (15%). This specific down-regulation of CYP2B1 was mediated exclusively by TNFalpha, released from the Kupffer cells. It was not linked with NO release from or inducible NO synthase activity in the hepatocytes. The TNFalpha release was not affected by the two xenobiotics. Acetaminophen tested in these cocultures showed no direct interaction with the Kupffer cells. The use of liver cell cocultures is therefore a useful approach to investigate the influence of intercellular communication on xenobiotic metabolism in liver.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10096772     DOI: 10.1016/s0014-2999(98)00988-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  26 in total

1.  An Expandable Mechanopharmaceutical Device (2): Drug Induced Granulomas Maximize the Cargo Sequestering Capacity of Macrophages in the Liver.

Authors:  Phillip Rzeczycki; Gi Sang Yoon; Rahul K Keswani; Sudha Sud; Jason Baik; Mikhail D Murashov; Ingrid L Bergin; Kathleen A Stringer; Gus R Rosania
Journal:  Pharm Res       Date:  2018-11-07       Impact factor: 4.200

2.  Evaluation of the HC-04 cell line as an in vitro model for mechanistic assessment of changes in hepatic cytochrome P450 3A during adenovirus infection.

Authors:  Piyanuch Wonganan; Kristina Jonsson-Schmunk; Shellie M Callahan; Jin Huk Choi; Maria A Croyle
Journal:  Drug Metab Dispos       Date:  2014-04-24       Impact factor: 3.922

3.  Metabolite profiling and pharmacokinetic evaluation of hydrocortisone in a perfused three-dimensional human liver bioreactor.

Authors:  Ujjal Sarkar; Dinelia Rivera-Burgos; Emma M Large; David J Hughes; Kodihalli C Ravindra; Rachel L Dyer; Mohammad R Ebrahimkhani; John S Wishnok; Linda G Griffith; Steven R Tannenbaum
Journal:  Drug Metab Dispos       Date:  2015-04-29       Impact factor: 3.922

4.  Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies.

Authors:  O B Usta; W J McCarty; S Bale; M Hegde; R Jindal; A Bhushan; I Golberg; M L Yarmush
Journal:  Technology (Singap World Sci)       Date:  2015-03

5.  Advancements in in vitro hepatic models: application for drug screening and therapeutics.

Authors:  Apeksha Damania; Era Jain; Ashok Kumar
Journal:  Hepatol Int       Date:  2013-12-05       Impact factor: 6.047

Review 6.  Drug disposition in pathophysiological conditions.

Authors:  Adarsh Gandhi; Bhagavatula Moorthy; Romi Ghose
Journal:  Curr Drug Metab       Date:  2012-11       Impact factor: 3.731

Review 7.  Emerging In Vitro Liver Technologies for Drug Metabolism and Inter-Organ Interactions.

Authors:  Shyam Sundhar Bale; Laura Moore; Martin Yarmush; Rohit Jindal
Journal:  Tissue Eng Part B Rev       Date:  2016-06-01       Impact factor: 6.389

8.  Long-term culture and coculture of primary rat and human hepatocytes.

Authors:  Maria Shulman; Yaakov Nahmias
Journal:  Methods Mol Biol       Date:  2013

9.  Induction of cytochrome P450 2B6 and 3A4 expression by phenobarbital and cyclophosphamide in cultured human liver slices.

Authors:  Hélène Martin; Jean-Pierre Sarsat; Isabelle de Waziers; Chantal Housset; Pierre Balladur; Philippe Beaune; Véronique Albaladejo; Carole Lerche-Langrand
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

10.  Modulation of Kupffer cells on hepatic drug metabolism.

Authors:  Hong Ding; Jing Tong; Shi-Cheng Wu; Deng-Ke Yin; Xian-Fen Yuan; Jian-Yuan Wu; Jun Chen; Gang-Gang Shi
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.